$CLNE
Clean Energy Fuels Corp.

2023 Q2 Form 10-Q Financial Statement

#000155837023008832 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $90.55M $132.2M
YoY Change -6.87% 58.31%
Cost Of Revenue $64.16M $127.3M
YoY Change -10.96% 98.12%
Gross Profit $26.39M $4.915M
YoY Change 4.86% -74.48%
Gross Profit Margin 29.14% 3.72%
Selling, General & Admin $28.55M $29.65M
YoY Change 7.81% 6.17%
% of Gross Profit 108.19% 603.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.89M $10.68M
YoY Change 3.19% -6.25%
% of Gross Profit 41.28% 217.25%
Operating Expenses $28.55M $29.65M
YoY Change 7.81% 6.17%
Operating Profit -$13.06M -$35.41M
YoY Change 9.96% 76.56%
Interest Expense -$3.514M -$3.527M
YoY Change 144.88% -21.45%
% of Operating Profit
Other Income/Expense, Net $28.00K $43.00K
YoY Change 100.0% 115.0%
Pretax Income -$16.54M -$38.90M
YoY Change 24.42% 58.58%
Income Tax -$100.0K -$100.0K
% Of Pretax Income
Net Earnings -$16.30M -$38.70M
YoY Change 23.17% 59.96%
Net Earnings / Revenue -18.0% -29.28%
Basic Earnings Per Share -$0.07 -$0.17
Diluted Earnings Per Share -$0.07 -$0.17
COMMON SHARES
Basic Shares Outstanding 222.9M 222.7M
Diluted Shares Outstanding 222.9M 222.7M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $191.7M $219.9M
YoY Change 2.24% -3.77%
Cash & Equivalents $53.15M $164.8M
Short-Term Investments $138.6M $55.11M
Other Short-Term Assets $49.56M $46.30M
YoY Change -24.02% -17.41%
Inventory $38.52M $38.05M
Prepaid Expenses
Receivables $74.75M $107.9M
Other Receivables $27.09M $20.08M
Total Short-Term Assets $392.4M $441.5M
YoY Change 3.79% 7.01%
LONG-TERM ASSETS
Property, Plant & Equipment $355.6M $334.7M
YoY Change 20.13% 11.9%
Goodwill $64.33M $64.33M
YoY Change 0.0% 0.0%
Intangibles $6.365M $6.365M
YoY Change 7.61% 15.73%
Long-Term Investments $196.8M $192.0M
YoY Change 24.86% 77.31%
Other Assets
YoY Change
Total Long-Term Assets $654.0M $628.1M
YoY Change 17.59% 20.76%
TOTAL ASSETS
Total Short-Term Assets $392.4M $441.5M
Total Long-Term Assets $654.0M $628.1M
Total Assets $1.046B $1.070B
YoY Change 12.0% 14.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.94M $39.14M
YoY Change 19.49% 52.89%
Accrued Expenses $76.61M $97.54M
YoY Change 10.48% 56.43%
Deferred Revenue $3.329M $4.356M
YoY Change -40.69% -40.94%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $38.00K $37.00K
YoY Change -99.48% -99.63%
Total Short-Term Liabilities $128.3M $151.8M
YoY Change 1.82% 32.09%
LONG-TERM LIABILITIES
Long-Term Debt $144.8M $144.9M
YoY Change 477.29% 465.59%
Other Long-Term Liabilities $8.908M $9.653M
YoY Change 4.64% 18.62%
Total Long-Term Liabilities $153.7M $154.5M
YoY Change 357.55% 357.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $128.3M $151.8M
Total Long-Term Liabilities $153.7M $154.5M
Total Liabilities $343.5M $365.9M
YoY Change 67.76% 88.2%
SHAREHOLDERS EQUITY
Retained Earnings -$885.0M -$868.7M
YoY Change 9.44% 9.21%
Common Stock $1.582B $1.568B
YoY Change 3.19% 2.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $695.7M $696.4M
YoY Change
Total Liabilities & Shareholders Equity $1.046B $1.070B
YoY Change 12.0% 14.68%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$16.30M -$38.70M
YoY Change 23.17% 59.96%
Depreciation, Depletion And Amortization $10.89M $10.68M
YoY Change 3.19% -6.25%
Cash From Operating Activities $12.04M -$19.00M
YoY Change -56.05% -492.73%
INVESTING ACTIVITIES
Capital Expenditures $29.91M $17.78M
YoY Change -396.7% 141.34%
Acquisitions
YoY Change
Other Investing Activities -$92.63M $78.30M
YoY Change 50.18% 797.1%
Cash From Investing Activities -$122.5M $60.52M
YoY Change 70.76% 4343.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.420M -772.0K
YoY Change -76.05% -83.94%
NET CHANGE
Cash From Operating Activities 12.04M -19.00M
Cash From Investing Activities -122.5M 60.52M
Cash From Financing Activities -1.420M -772.0K
Net Change In Cash -111.9M 40.86M
YoY Change 122.55% 2598.61%
FREE CASH FLOW
Cash From Operating Activities $12.04M -$19.00M
Capital Expenditures $29.91M $17.78M
Free Cash Flow -$17.87M -$36.78M
YoY Change -147.67% 1355.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
222907780
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125950000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
274136000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166807000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
139569000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
55113000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1375000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1462000
CY2023Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsNetOfTax
461000
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91430000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107896000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
17026000
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
20078000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-23000
CY2022Q4 us-gaap Inventory Net
InventoryNet
37144000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
244000
CY2023Q1 us-gaap Inventory Net
InventoryNet
38045000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
60601000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53569000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
471720000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
441508000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52586000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60573000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
264068000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
30467000
CY2023Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
30740000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
193273000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
191981000
CY2022Q4 us-gaap Goodwill
Goodwill
64328000
CY2023Q1 us-gaap Goodwill
Goodwill
64328000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5915000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6365000
CY2022Q4 us-gaap Assets
Assets
1082357000
CY2023Q1 us-gaap Assets
Assets
1069631000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
37000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
948000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1008000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4206000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4558000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44435000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
39144000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90079000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
97537000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5970000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6099000
CY2022Q4 clne Derivative Liability Current Related Party
DerivativeLiabilityCurrentRelatedParty
2415000
CY2023Q1 clne Derivative Liability Current Related Party
DerivativeLiabilityCurrentRelatedParty
3373000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
249000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
148146000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222559648
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222717113
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001368265
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
222437429
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q1 us-gaap Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax
CY2022Q1 us-gaap Fair Value Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Fair Value Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
222907780
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33480
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CLEAN ENERGY FUELS CORP.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0968580
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4675 MacArthur Court
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
CY2023Q1 dei City Area Code
CityAreaCode
949
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
437-1000
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
CLNE
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
151756000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
145471000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3188000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
144877000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2134000
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2231000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48911000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56843000
CY2022Q4 clne Derivative Liability Noncurrent Related Party
DerivativeLiabilityNoncurrentRelatedParty
1430000
CY2023Q1 clne Derivative Liability Noncurrent Related Party
DerivativeLiabilityNoncurrentRelatedParty
502000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8794000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9653000
CY2022Q4 us-gaap Liabilities
Liabilities
354886000
CY2023Q1 us-gaap Liabilities
Liabilities
365862000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
222437429
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
222907780
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
22000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1553668000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1568093000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-829975000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-868672000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3722000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3017000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
719993000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
696426000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
7478000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
7343000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
727471000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
703769000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1082357000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1069631000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83497000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132183000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27927000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29649000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11390000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10678000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
103554000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
167595000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20057000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-35412000
CY2022Q1 clne Interest Expense Nonoperating
InterestExpenseNonoperating
3077000
CY2023Q1 clne Interest Expense Nonoperating
InterestExpenseNonoperating
4354000
CY2022Q1 clne Interest Income Nonoperating
InterestIncomeNonoperating
264000
CY2023Q1 clne Interest Income Nonoperating
InterestIncomeNonoperating
2717000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1677000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1890000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24527000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38896000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-64000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-24576000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-385000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-135000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24191000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-38697000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222559648
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222717113
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-24576000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2022Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsTax
0
CY2023Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsTax
0
CY2022Q1 clne Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Excluding Intra Entity Investments Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentExcludingIntraEntityInvestmentsNetOfTax
272000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-24327000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-38127000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
755411000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
273000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3001000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8253000
CY2022Q1 clne Apic Share Based Payment Arrangement Increase For Sales Incentive Charges
ApicShareBasedPaymentArrangementIncreaseForSalesIncentiveCharges
1721000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-24576000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
249000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
738330000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
727471000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
332000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
175000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6096000
CY2023Q1 clne Apic Share Based Payment Arrangement Increase For Sales Incentive Charges
ApicShareBasedPaymentArrangementIncreaseForSalesIncentiveCharges
8172000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
703769000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-24576000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38832000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11390000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10678000
CY2022Q1 clne Provision For Doubtful Accounts Notes And Inventory
ProvisionForDoubtfulAccountsNotesAndInventory
375000
CY2023Q1 clne Provision For Doubtful Accounts Notes And Inventory
ProvisionForDoubtfulAccountsNotesAndInventory
502000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8253000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6096000
CY2022Q1 clne Contra Revenue From Contract With Customer Excluding Assessed Tax
ContraRevenueFromContractWithCustomerExcludingAssessedTax
3756000
CY2023Q1 clne Contra Revenue From Contract With Customer Excluding Assessed Tax
ContraRevenueFromContractWithCustomerExcludingAssessedTax
13730000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1036000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2532000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-47000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-1213000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
32000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
49000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2268000
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
409000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1677000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1890000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
827000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1402000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-86000
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-12875000
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
19704000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1809000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2626000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1040000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-971000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1105000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
113000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-606000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
801000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
129000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7930000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6809000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4839000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19004000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
99803000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49393000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
109000000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
135500000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7366000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17777000
CY2022Q1 clne Grant Proceeds For Capital Projects
GrantProceedsForCapitalProjects
0
CY2023Q1 clne Grant Proceeds For Capital Projects
GrantProceedsForCapitalProjects
1947000
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1140000
CY2022Q1 clne Proceeds From Collection And Sale Of Loans Receivable
ProceedsFromCollectionAndSaleOfLoansReceivable
103000
CY2023Q1 clne Proceeds From Collection And Sale Of Loans Receivable
ProceedsFromCollectionAndSaleOfLoansReceivable
1483000
CY2022Q1 clne Cash Received Net Of Transferred Cash From Sale Of Subsidiary
CashReceivedNetOfTransferredCashFromSaleOfSubsidiary
3885000
CY2023Q1 clne Cash Received Net Of Transferred Cash From Sale Of Subsidiary
CashReceivedNetOfTransferredCashFromSaleOfSubsidiary
0
CY2022Q1 clne Payment Of Deposit On Property And Equipment
PaymentOfDepositOnPropertyAndEquipment
4500000
CY2023Q1 clne Payment Of Deposit On Property And Equipment
PaymentOfDepositOnPropertyAndEquipment
10147000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
43000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
49000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1362000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60522000
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
273000
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
332000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3001000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
175000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
369000
CY2022Q1 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
240000
CY2023Q1 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
100000
CY2022Q1 clne Repayments Of Proceeds From Adopt Port Program Partnership Contribution
RepaymentsOfProceedsFromAdoptPortProgramPartnershipContribution
235000
CY2023Q1 clne Repayments Of Proceeds From Adopt Port Program Partnership Contribution
RepaymentsOfProceedsFromAdoptPortProgramPartnershipContribution
343000
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
14000000
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
CY2022Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
13848000
CY2023Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
317000
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2186000
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4807000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-772000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1514000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40857000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106456000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125950000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107970000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166807000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26000
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
138000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
470000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4106000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying condensed consolidated financial statements and these notes. Actual results could differ from those estimates and may result in material effects on the Company’s operating results and financial position. Significant estimates made in preparing the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">accompanying condensed consolidated financial statements include (but are not limited to) those related to revenue recognition, fair value measurements, goodwill and long-lived asset valuations and impairment assessments, income tax valuations, stock-based compensation expense and stock-based sales incentive charges.</p>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83497000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132183000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
27900000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91430000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107896000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6063000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7266000
CY2022Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
2976000
CY2023Q1 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
2837000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
9039000
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10103000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5477000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4356000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5477000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4356000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1300000
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
8000000.0
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123950000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164807000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125950000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166807000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125950000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166807000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
124800000
CY2023Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
165600000
CY2023Q1 us-gaap Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
2000000.0
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
139915000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
346000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
139569000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
55297000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
184000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
55113000
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
17026000
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
20078000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
37144000
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
38045000
CY2022Q4 us-gaap Inventory Net
InventoryNet
37144000
CY2023Q1 us-gaap Inventory Net
InventoryNet
38045000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
721912000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
742026000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
457844000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
467890000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
264068000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
274136000
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
35300000
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
35600000
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
32100000
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
32600000
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
300000
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
400000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12900000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7800000
CY2022Q4 clne Accrued Alternative Fuel Incentives Current
AccruedAlternativeFuelIncentivesCurrent
34239000
CY2023Q1 clne Accrued Alternative Fuel Incentives Current
AccruedAlternativeFuelIncentivesCurrent
47532000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5128000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3728000
CY2022Q4 clne Accrued Gas And Equipment Purchase Current
AccruedGasAndEquipmentPurchaseCurrent
22008000
CY2023Q1 clne Accrued Gas And Equipment Purchase Current
AccruedGasAndEquipmentPurchaseCurrent
14898000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1827000
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1798000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3782000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
6650000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6857000
clne Stock Repurchase Program Total Stock Repurchased
StockRepurchaseProgramTotalStockRepurchased
9387340
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4679000
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0
CY2023Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
164000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16238000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18088000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90079000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
97537000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
150093000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4529000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
145564000
CY2022Q4 clne Long Term Debt Gross Current Maturities
LongTermDebtGrossCurrentMaturities
93000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93000
CY2022Q4 clne Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
150000000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4529000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
145471000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
150037000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5123000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
144914000
CY2023Q1 clne Long Term Debt Gross Current Maturities
LongTermDebtGrossCurrentMaturities
37000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
37000
CY2023Q1 clne Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
150000000
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
5123000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
144877000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24191000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-38697000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222559648
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222717113
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222559648
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222717113
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
26500000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76150364
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77171311
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
8253000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6096000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28400000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4300000
CY2021Q2 clne Shares Authorized
SharesAuthorized
304000000
CY2021Q2 clne Shares Authorized
SharesAuthorized
454000000
CY2023Q1 clne Shares Authorized
SharesAuthorized
455000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
454000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0
clne Stock Repurchase Program Repurchased Amount
StockRepurchaseProgramRepurchasedAmount
23500000
CY2023Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
800000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.07
CY2022Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
100000
CY2023Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
100000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
721000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
962000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
962000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
985000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
1105000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
1218000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
5953000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
1350000
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
4603000
CY2022Q1 clne Alternative Fuels Excise Tax Credit Compressed Natural Gas
AlternativeFuelsExciseTaxCreditCompressedNaturalGas
0.50
CY2022Q1 clne Alternative Fuels Excise Tax Credit Liquefied Natural Gas
AlternativeFuelsExciseTaxCreditLiquefiedNaturalGas
0.50
CY2023Q1 clne Repayments Of Loan Commitment With Equity Method Investee
RepaymentsOfLoanCommitmentWithEquityMethodInvestee
1100000

Files In Submission

Name View Source Status
clne-20230331_cal.xml Edgar Link unprocessable
0001558370-23-008832-index-headers.html Edgar Link pending
0001558370-23-008832-index.html Edgar Link pending
0001558370-23-008832.txt Edgar Link pending
0001558370-23-008832-xbrl.zip Edgar Link pending
clne-20230331.xsd Edgar Link pending
clne-20230331x10q.htm Edgar Link pending
clne-20230331xex31d1.htm Edgar Link pending
clne-20230331x10q_htm.xml Edgar Link completed
clne-20230331xex31d2.htm Edgar Link pending
clne-20230331xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
clne-20230331_def.xml Edgar Link unprocessable
clne-20230331_pre.xml Edgar Link unprocessable
clne-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending